Advanced Filters
noise

Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 630 clinical trials
M Ming Yu, PhD, MD

Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors

To explore an effective noninvasive method for differential diagnosis of liver tumors.

18 - 70 years of age All Phase N/A
M Mario Mondelli, MD

Immunotherapy: Care and Prevention of Infectious and Tumoral Diseases (ImmunoHUB)

The project comprises two research lines. In the line 1, human monoclonal antibodies toward SARS-CoV-2 will be generate and characterized by in vitro functional tests. In the line 2, in vitro tests will be performed to evaluate the efficency of immune response mediated by antibodies direct to specific tumor molecules.

18 - 90 years of age All Phase N/A
B Bo Hu, Doctor

PDO/PDO-TIL/PDOTS for Drug Screen

This clinical trial aims to use the patient-derived organoid (PDO), Patient-derived organoids-tumor-infiltrating lymphocyte coculture system (PDO-TIL) and patient-derived organotypic tissue spheroids (PDOTS) to simulate the tumor microenvironment in cancer patients. The culture system can be used for pre-clinical validation of drugs and screening of drugs to treat sensitive people and …

18 - 90 years of age All Phase N/A
P Principal Investigator

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

This observational study will investigate the properties of image files standardly collected during radiation therapy treatment in a cross-section of liver cancer patients who received stereotactic ablative body radiation therapy (SABR) after trans-catheter arterial chemo emobilisation (TACE). Specifically, it will determine whether the radio-opaque contrast agents in the image files …

18 years of age All Phase N/A
J Julien Calderaro

Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma

Our project is a large-scale characterisation of cHCC-CCA will allow us to determine which subsets harbor actionable gene alterations. We will also aim to improve diagnosis of this tumor type by the use of immunohistochemical biomarkers and the development of deep-learning based models able to help cHCC-CCA diagnosis. This will …

18 years of age All Phase N/A
M Mei-Sze Chua

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy, so that it can be used alone or in conjunction with alpha-feto protein (AFP)

18 years of age All Phase N/A
T Theoni Kaplanidou

The AMARA (As Much As Reasonably Achievable) Study

Subjects with large inoperable liver tumors defined as at least 1 lesion larger than 5cm in maximum diameter. For the purposes of the present study, we define the AMARA principle in intensified regional TARE as a planned irradiated tumor dose >200Gy by the partition model. The purpose of the study …

18 years of age All Phase N/A
O Olivier SUTTER

Evaluation of the Ablation of Hepatic Lesions by Electroporation

Irreversible electroporation is a curative treatment for cancerous liver lesions, performed on deep-seated tumors that are not eligible for surgical resection or percutaneous thermal ablation. The EVALHEP project aims to develop criteria for evaluating the effectiveness of the treatment based on imaging, mathematical models, and numerical simulations to assist radiologists …

18 years of age All Phase N/A
P Pintong Huang, director

Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS

Liver cancer (LC) is the sixth most common malignant tumor and the third cause of cancer mortality in the world. According to the 2018 United States Association for the Study of Liver Diseases guidelines for the diagnosis and treatment of liver cancer, patients with HCC high-risk factors can be directly …

18 years of age All Phase N/A
J Jessica Hwang, MD, MPH

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

To develop and test liver cancer prevention educational material.

18 years of age All Phase N/A

Simplify language using AI